PET study for Brain Tumor

Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix, AZ
Brain TumorPET imaging with 18F fluciclovine - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if PET imaging can detect cancer spread earlier than MRI, helping to better tailor treatments.

Eligible Conditions
  • Brain Tumor

Treatment Effectiveness

Phase-Based Effectiveness

2 of 3
Phase 3
This is further along than 85% of similar trials

Similar Trials

1
18F-Fluciclovine PET-MRI in pediatric HGG or DMG participants
1
18F-FMISO PET
1
PET/CT, MRI

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 20 weeks

20 weeks
Brain tumor progression
PET uptake and dynamic susceptibility contrast (DSC) perfusion

Trial Safety

Phase-Based Safety

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
18F-Fluciclovine PET-MRI in pediatric HGG or DMG participants
1
18F-FMISO PET
2
PET/CT, MRI

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

PET study
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: PET study · No Placebo Group · Phase 3

PET study
Drug
Experimental Group · 1 Intervention: PET imaging with 18F fluciclovine · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 20 weeks

Who is running the clinical trial?

Blue Earth DiagnosticsIndustry Sponsor
29 Previous Clinical Trials
2,692 Total Patients Enrolled
Nicole HillLead Sponsor
1 Previous Clinical Trials
140 Total Patients Enrolled
Barrow Neurological FoundationOTHER
7 Previous Clinical Trials
21,557 Total Patients Enrolled
Poonam Choudhary, PhDPrincipal InvestigatorBarrow Neurological Institute

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the FDA's current stance on PET study?

"There is some efficacy data from Phase 3 trials to support the safety of PET scans, so our team gives it a score of 3." - Anonymous Online Contributor

Unverified Answer

Are people with the required qualifications able to sign up for this clinical trial right now?

"The trial is presently looking for patients, as seen on clinicaltrials.gov. This study was originally posted on 8/24/2022, with the latest update being on 10/25/2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top